Last reviewed · How we verify

Regional analgesia and propofol — Competitive Intelligence Brief

Regional analgesia and propofol (Regional analgesia and propofol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic + sedative-hypnotic combination. Area: Anesthesiology / Perioperative Medicine.

phase 3 Local anesthetic + sedative-hypnotic combination Anesthesiology / Perioperative Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Regional analgesia and propofol (Regional analgesia and propofol) — The Cleveland Clinic. Regional analgesia with propofol combines local anesthetic nerve blockade with intravenous sedation to provide perioperative pain control and anxiolysis.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Regional analgesia and propofol TARGET Regional analgesia and propofol The Cleveland Clinic phase 3 Local anesthetic + sedative-hypnotic combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic + sedative-hypnotic combination class)

  1. The Cleveland Clinic · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Regional analgesia and propofol — Competitive Intelligence Brief. https://druglandscape.com/ci/regional-analgesia-and-propofol. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: